Top Markets
#1 MowCat MowCat +48.87%
#2 Velvet Velvet +25.75%
#3 Quack AI Quack AI +21.37%
#4 Derive Derive +19.45%
#5 Bermuda Shorts Bermuda Shorts +15.70%
#6 Geodnet Geodnet +15.17%
#7 SkyAI SkyAI +14.51%
#8 aPriori aPriori +11.70%
#9 Cross Cross +11.69%
#10 Biconomy Biconomy +11.68%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
Classifica tra le azioni #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
Prezzo delle azioni
$2.70
Ultima sincronizzazione: 2023-05-17
Capitalizzazione di mercato
$4.13M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Graybug Vision, Inc. (GRAY)

Categoria

Healthcare
Storico del prezzo dell'azione per Graybug Vision, Inc. (GRAY)
Prezzo di chiusura più alto: $3.07 il 2023-05-01

Prezzo di chiusura più basso: $208.50 il 2020-09-01
Storico del prezzo dell'azione di Graybug Vision, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2023 -59.99%
2022 -72.75%
2021 -92.01%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE